Physician profile
Jorge Baez
NPI 1578668315
$3,793.84
in general payments reported to CMS, 2019-2025
23 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $62.13 · 2021: $165 · 2022: $645 · 2023: $774 · 2024: $598 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,062.53 | 2019-2025 | Mako, Triathlon, Pangea |
| Depuy Synthes Sales INC. | $578.51 | 2019-2025 | Attune, Actis, Monovisc |
| Ferring Pharmaceuticals INC. | $531.52 | 2019-2025 | Euflexxa |
| Nuvasive, INC. | $351.72 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $210.16 | 2019 | |
| Linvatec Corporation | $169.58 | 2022-2023 | Biobrace 23mm |
| Baxter Healthcare | $166.02 | 2022-2023 | Actifuse |
| Bioventus LLC | $107.80 | 2024-2025 | Durolane, Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Medical Device Business Services, INC. | $104.34 | 2023 | Attune |
| Vertex Pharmaceuticals Incorporated | $89.71 | 2024-2025 | |
| Djo, LLC | $79.71 | 2023 | Cmf |
| Sanofi-Aventis U.S. LLC | $49.38 | 2019-2020 | |
| Smith+Nephew, INC. | $44.46 | 2019-2020 | |
| Horizon Therapeutics Plc | $40.31 | 2019-2022 | |
| Heraeus Medical, LLC. | $33.93 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $25.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.88 | 2025 | Exparel |
| Endo Pharmaceuticals INC. | $24.51 | 2023 | Xiaflex |
| Kci USA, INC. | $23.31 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.06 | 2019 | |
| Acumed LLC | $19.09 | 2023 | Osteomed |
| Convatec INC. | $18.01 | 2019 | |
| Genzyme Corporation | $17.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Baez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.